Page 1358 - Small Animal Internal Medicine, 6th Edition
P. 1358

1330   PART XII   Oncology


            dozen cutaneous MCTs, which on histopathologic evalua-  Diagnosis
            tion are all considered low grade.                   The evaluation of a dog with a suspected MCT should
  VetBooks.ir  and a higher potential for systemic dissemination than grade   nose cytologically. They consist of a monomorphic popula-
                                                                 include FNA of the mass. MCTs are typically easy to diag-
              Grade 2 and 3 tumors have a higher metastatic potential
                                                                 tion of round cells with prominent intracytoplasmic purple
            1 MCTs. The newer Kiupel grading scheme helps clinicians
            determine how concerned to be about a specific MCT, which   granules; eosinophils are frequently present in the smear (see
            is especially helpful for MCTs with a grade 2 designation   Fig. 74.8). In approximately one fourth to one third of MCTs,
            (under the Patnaik system), as some of these are categorized   the granules do not stain with Diff-Quik; hence if agranular
            as low grade and some high grade. Grade 2, high-grade   round  cells  are  found  in  a  dermal  or  subcutaneous  mass
            MCTs have a higher potential for metastasis and systemic   resembling an MCT, the clinician should stain the slide with
            dissemination than grade 2, low-grade MCTs. Metastases to   Giemsa or Wright stain to reveal the characteristic purple
            the regional lymph nodes commonly occur (particularly in   granules (see  Fig. 74.13). A cytologic diagnosis of MCT
            dogs with high-grade tumors), although occasionally a   allows the clinician to discuss treatment options with the
            tumor “skips” the draining lymph node and metastasizes to   owner and to plan therapeutic strategies (see the section on
            the second or third regional node (e.g., a digital MCT in the   treatment and prognosis).
            rear limb metastasizing to the iliac or sublumbar node).   Although clinical pathologists frequently state the degree
            Because nodal metastases can be present in normal-size   of differentiation of the cells in a cytologic specimen of an
            lymph nodes, every lymph node in the region of a MCT should   MCT, that scheme does not necessarily correlate with the
            be aspirated before an aggressive surgery, regardless of   histopathologic grading system. In other words, a cytologic
            whether it is enlarged or not. Pulmonary metastases are   diagnosis of a well-differentiated MCT does not necessarily
            extremely rare. It also appears that MCTs in certain anatomic   imply that it will be a low-grade tumor when evaluated his-
            locations are more aggressive than tumors in other areas. For   topathologically (i.e., cytologic grading may not have the
            example, distal limb (e.g., toe), perineal, preputial, scrotal,   same  prognostic  implications  as  histopathologic  grading).
            inguinal, muzzle, and extracutaneous (e.g., oropharyngeal,   More recently, a variation of the Kiupel grading scheme was
            intranasal) MCTs appear to have a higher metastatic poten-  successfully applied to  152 cytologic specimens.  Tumors
            tial than similarly graded tumors in other regions (e.g.,   were classified as high grade if the cells were poorly granu-
            trunk, neck).                                        lated or had at least two of four findings: mitotic figures,
              Another  biologic  characteristic  of  canine  MCTs  is  that   binucleated or multinucleated cells, nuclear pleomorphism,
            they may become systemic, behaving like a hematopoietic   or >50% anisokaryosis. This cytologic grading scheme had
            malignancy (i.e., a lymphoma or leukemia). These dogs   88% sensitivity and 94% specificity relative to histologic
            usually have a history of a high-grade or grade 3 cutaneous   grading (Camus et al., 2016).
            MCT that was excised, or a MCT in one of the locations   The clinical evaluation of a dog with a cytologically con-
            described earlier. Most dogs with systemic mast cell disease   firmed MCT should include careful palpation of the affected
            (SMCD) are evaluated because of lethargy, anorexia, vomit-  area and its draining lymph nodes; abdominal palpation,
            ing, and weight loss in association with splenomegaly, hepa-  radiography, or ultrasonography to search for hepatospleno-
            tomegaly,  pallor,  and  (occasionally)  detectable  cutaneous   megaly; a CBC, serum biochemistry profile, and urinalysis;
            masses. The CBC in affected dogs commonly reveals cytope-  and thoracic radiography if the neoplasm is in the cranial half
            nias, with or without circulating mast cells.        of the body (i.e., to detect intrathoracic lymphadenopathy).
              MCTs can release bioactive substances that may cause   Abdominal ultrasonography should be strongly considered
            edema, erythema, or bruising of the affected area. Gastro-  in dogs with clinical negative prognostic factors, including
            intestinal tract ulceration may also occur as a result of hyper-  an enlarged regional lymph node on physical examination, a
            histaminemia (≈80% of dogs euthanized because of advanced   MCT in any “high risk” location described earlier, an ulcer-
            MCTs have gastroduodenal ulceration). Therefore any dog   ated MCT, history of rapid growth, known recurrence of a
            with an MCT should be considered to have an increased risk   previous MCT, systemic signs that may indicate dissemina-
            of gastroduodenal ulceration. Profuse intraoperative and   tion, or certain breeds. For example, in a recent study Shih
            postoperative bleeding and delayed wound healing occur in   Tzus and Rottweilers were reported to have a higher preva-
            some dogs as a consequence of the bioactive substances   lence of high-grade MCTs (Mochizuki et al., 2017)
            released from mast cells.                              If lymphadenopathy, hepatomegaly, or splenomegaly is
              A clinical presentation with a very distinctive biological   present, FNA of the enlarged lymph node or organ should
            behavior is the subcutaneous MCT (Thompson et al., 2011).   be performed to detect mast cells (i.e., local neoplasm versus
            Most dogs with subcutaneous MCT have a “lipoma”-feeling   metastatic tumor versus SMCD); as discussed earlier, regional
            mass, usually in the leg (although other locations are possi-  nodes should be aspirated, even if normal in size, before
            ble). FNAs of these masses usually yield well-granulated   performing an aggressive surgery. Additionally, dogs with
            mast cells, with no anisocytosis or mitotic figures. This clini-  ultrasonographically normal liver and spleen can still have
            cal entity is very different than a “deep” dermal MCT, because   cytologic evidence of MCT metastasis, so aspirating these
            most dogs with subcutaneous MCTs are cured by surgical   organs in dogs that have negative prognostic indicators (see
            excision alone, even when the tumor is incompletely excised.  previous discussion) is recommended.
   1353   1354   1355   1356   1357   1358   1359   1360   1361   1362   1363